Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-SOST, LY2541546 Vector   (CAT#: GTVCR-WQ1752MR)

This product GTVCR-WQ1752MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting SOST. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Humanized
RefSeq NM_025237.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 50964
UniProt ID Q9BQB4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-SOST, LY2541546 Vector (GTVCR-WQ1752MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1791MR IVTScrip™ pT7-VEE-mRNA-Anti-ALB&IL17A, M-1095 Vector Vector M-1095
GTVCR-WQ1890MR IVTScrip™ pSP6-VEE-mRNA-Anti-hly, MEDI4893 Vector Vector MEDI4893
GTVCR-WQ1023MR IVTScrip™ pT7-VEE-mRNA-Anti-IL23A, CNTO-1959 Vector Vector CNTO-1959
GTVCR-WQ986MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD40, CHIR-12,12 Vector Vector CHIR-12,12
GTVCR-WQ2407MR IVTScrip™ pT7-VEE-mRNA-Anti-IFNA1, RhuMAB IFNalpha Vector Vector RhuMAB IFNalpha
GTVCR-WQ2280MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFSF4, R4930 Vector Vector R4930
GTVCR-WQ361MR IVTScrip™ pSP6-VEE-mRNA-Anti-IFNAR1&IFNAR2, Alb-IFNA2 R23 (608) Vector Vector Alb-IFNA2 R23 (608)
GTVCR-WQ1993MR IVTScrip™ pSP6-VEE-mRNA-Anti-CCR2, MLN-1202 Vector Vector MLN-1202
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.